Conference Coverage

Stage I mycosis fungoides is the general dermatologist’s bailiwick


 

REPORTING FROM SDEF HAWAII DERMATOLOGY SEMINAR


When to suspect mycosis fungoides

“Mycosis fungoides is a great masquerader,” the dermatologist observed. For that reason, it deserves to be included in the differential diagnosis of an atypical psoriasiform or eczematoid rash, any new-onset rash in an elderly patient, or a rash with fever, night sweats, and unintended weight loss in a patient of any age. Generalized erythema with severe itching is another red flag.

“This pruritus is so severe that the only other condition which in my clinical practice would match it is Norwegian scabies,” according to Dr. Tejasvi.

Polychromatic patches or plaques in skin of color warrant further investigation as possible mycosis fungoides, he added.

Dr. Tejasvi reported having no financial conflicts of interest regarding his presentation.

SDEF/Global Academy for Medical Education and this news organization are owned by the same parent company.

Pages

Recommended Reading

SCC survival remains poor in epidermolysis bullosa
MDedge Hematology and Oncology
Short-course calcipotriol plus 5-FU for AKs: potential major public health impact
MDedge Hematology and Oncology
Largest meeting on cancer research canceled: AACR
MDedge Hematology and Oncology
Patients accept artificial intelligence in skin cancer screening
MDedge Hematology and Oncology
Merkel cell carcinoma management undergoes revolution
MDedge Hematology and Oncology
Teledermoscopy using smartphones fails to boost skin cancer detection
MDedge Hematology and Oncology
Disruptions in cancer care in the era of COVID-19
MDedge Hematology and Oncology
How is oncology adapting to COVID-19?
MDedge Hematology and Oncology
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
MDedge Hematology and Oncology
Perspective from the heartland: Cancer care and research during a public health crisis
MDedge Hematology and Oncology